April 2, 2026

Science Chronicle

A Science and Technology Blog

April 2, 2026

Science Chronicle

A Science and Technology Blog

Clinical trial

Clinical trialCoronavirusPublic HealthSARS-CoV-2Vaccines

Completion of COVID-19 vaccine trials could take at least six-nine months, says Soumya Swaminathan

  A realistic (but very optimistic) timeline from the start of Phase-1 to the completion of Phase-3 could be about

Read More
Clinical trialCoronavirusCOVID-19ICMRPublic HealthSARS-CoV-2Vaccines

A day after ICMR faces flak, it reverses stand and says fast-tracking was only to cut red tape

A day after serious concerns were raised, ICMR has reversed its stand. It says its decision to fast-track the trial

Read More
Clinical trialCoronavirusHealthICMRPublic HealthSARS-CoV-2

ICMR threatens principal investigators to complete COVID-19 vaccine trial by August 15

On July 2, ICMR had sent a threatening letter sent to principal investigators at 12 sites to complete the Phase-1/phase-2

Read More
Clinical trialCoronavirusHealthPublic HealthSARS-CoV-2Vaccines

Why developing, manufacturing COVID-19 vaccines in India becomes important

With the pandemic raging across many countries and the demand for a safe, efficacious vaccine being huge, availability of an

Read More
Clinical trialCoronavirusHealthPublic HealthSARS-CoV-2Vaccines

Serum Institute may manufacture 2-3 million Oxford vaccine doses in July

The results of the Phase-1 clinical trial of the Oxford vaccine (ChAdOx1 nCoV-19) to prevent infection by novel coronavirus are

Read More
Clinical trialCoronavirusHealthPublic HealthSARS-CoV-2Vaccines

COVID-19: Two doses of Oxford vaccine boost immune responses in pigs

While a single dose induced antigen-specific antibody and T cells responses in pigs, the booster dose enhanced the antibody responses

Read More
Clinical trialCoronavirusHealthPublic HealthSARS-CoV-2

Gilead to begin testing inhaled remdesivir for early-stage treatment

Gilead plans to begin a Phase-1 clinical trial in August of an inhaled version of remdesivir for early-stage COVID-19 treatment

Read More
Clinical trialCoronavirusHealthPublic HealthSARS-CoV-2

Hydroxychloroquine does not prevent deaths, RECOVERY trial finds

The RECOVERY trial, a large randomised controlled trial in the UK to test five drugs, found that hydroxychloroquine drug did

Read More
Clinical trialCoronavirusHealthPublic HealthSARS-CoV-2

Remdesivir trial results: NEJM, NIAID and Gilead provide conflicting information

Information shared by the three stakeholders — NEJM, NIAID and Gilead — on critical issues about whether the drug’s ability

Read More
Clinical trialCoronavirusHealthPublic HealthSARS-CoV-2Vaccines

Phase-1 trial: Adenovirus COVID-19 vaccine found safe, induces immune responses

A phase-1 trial using a single dose of a vaccine (Ad5-nCoV) that uses a recombinant adenovirus type-5 vector that carries

Read More
Animal trialsClinical trialCoronavirusHealthHerd immunityPublic HealthSARS-CoV-2Vaccines

Monkeys resist coronavirus reinfection; six DNA vaccines show promise in animal studies

Six rhesus macaque monkeys were resistant to reinfection following exposure to novel coronavirus. Compared with nose, the lungs had very

Read More
Clinical trialCoronavirusHealthPublic HealthSARS-CoV-2

Recovery Trial for COVID-19 to test five drugs

The Recovery Trial will test five already approved drugs — HIV drug Lopinavir-Ritonavir,  anti-inflammatory corticosteroid (dexamethasone), anti-malaria drug hydroxychloroquine and

Read More
Clinical trialCoronavirusFDAHealthHuman challenge studiesNIHPublic HealthSARS-CoV-2VaccinesWorld Health Organisation

WHO backs COVID-19 vaccine trials that deliberately infect participants

In new guidelines issued on May 6, WHO has backed human challenge studies for COVID-19 vaccines on the ground that

Read More